We are live on ! Find out more
PRCT icon

Procept Biorobotics

120 hedge funds and large institutions have $1.27B invested in Procept Biorobotics in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 20 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more call options, than puts

Call options by funds: $17.1M | Put options by funds: $2.14M

195% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 20

36% more capital invested

Capital invested by funds: $938M → $1.27B (+$333M)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

18% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 22

6.42% more ownership

Funds ownership: 73.56%79.98% (+6.4%)

3% more funds holding

Funds holding: 116120 (+4)

Holders
120
Holders Change
+4
Holders Change %
+3.45%
% of All Funds
1.88%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
26
Increased
59
Reduced
20
Closed
22
Calls
$17.1M
Puts
$2.14M
Net Calls
+$15M
Net Calls Change
+$23.6M
Name Holding Trade Value Shares
Change
Change in
Stake
DCM
26
Driehaus Capital Management
Illinois
$8.51M -$21.2M -640,617 -73%
BNP Paribas Asset Management
27
BNP Paribas Asset Management
France
$7.9M +$7.39M +223,553 New
ACM
28
Atika Capital Management
New York
$7.14M -$1.41M -42,726 -17%
TD Asset Management
29
TD Asset Management
Ontario, Canada
$5.37M +$468K +14,140 +10%
SEI Investments
30
SEI Investments
Pennsylvania
$4.65M +$3.35M +101,422 +337%
TFCM
31
Taylor Frigon Capital Management
Arizona
$4.4M +$1.64M +49,665 +66%
Morgan Stanley
32
Morgan Stanley
New York
$4.38M -$481K -14,559 -11%
Jane Street
33
Jane Street
New York
$4.34M +$4.06M +122,726 New
JP Morgan Chase
34
JP Morgan Chase
New York
$4.31M +$1.35M +40,843 +50%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$4.3M +$1.05M +31,834 +35%
Aberdeen Group
36
Aberdeen Group
United Kingdom
$3.89M
NCGI
37
Next Century Growth Investors
Minnesota
$3.66M +$1.58M +47,862 +86%
LWM
38
Lyell Wealth Management
California
$3.39M
N
39
Nuveen
North Carolina
$3.38M +$803K +24,275 +34%
TOTUOP
40
Trustees of The University of Pennsylvania
Pennsylvania
$3.21M
TA
41
Tiedemann Advisors
New York
$3.05M
Swiss National Bank
42
Swiss National Bank
Switzerland
$2.94M +$1.95M +58,900 +243%
Goldman Sachs
43
Goldman Sachs
New York
$2.82M -$2.8M -84,821 -52%
HSBC Holdings
44
HSBC Holdings
United Kingdom
$2.59M +$2.43M +73,366 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.43M +$289K +8,729 +15%
Bank of America
46
Bank of America
North Carolina
$2.3M -$443K -13,409 -17%
LCG
47
Lisanti Capital Growth
New York
$2.18M +$2.04M +61,730 New
OCM
48
Osterweis Capital Management
California
$2.01M -$927K -28,050 -33%
RAM
49
Robocap Asset Management
United Kingdom
$1.96M +$1.09M +33,032 +148%
UOC
50
UBS O'Connor
Illinois
$1.81M +$303K +9,173 +22%

PRCT Hedge Fund Activity: Q2 2023 in Review

120 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q2 2023, worth a combined $1.27B — up 36% from $938M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PRCT positions and 22 closed out — a net gain of 4 holders — while 59 added to existing stakes and 20 trimmed.

The largest buyer was BlackRock, adding an estimated $22.6M. The largest seller was Driehaus Capital Management, cutting an estimated $21.2M.

  • 120 institutional investors held Procept Biorobotics (PRCT) as of Q2 2023, up from 116 in Q1 2023.
  • Funds reported $1.27B of Procept Biorobotics stock for Q2 2023, up 36% quarter-over-quarter.
  • 26 funds opened new Procept Biorobotics positions in Q2 2023 and 22 closed out, a net change of +4 holders.
  • The largest Procept Biorobotics buyer in Q2 2023 was BlackRock, an estimated $22.6M added.
  • The largest Procept Biorobotics seller in Q2 2023 was Driehaus Capital Management, an estimated $21.2M sold.

Based on aggregated 13F filings for Q2 2023.